Hawkins, Inc. (NASDAQ:HWKN – Get Free Report) Director James Faulconbridge acquired 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The stock was purchased at an average cost of $129.29 per share, for a total transaction of $193,935.00. Following the completion of the purchase, the director directly owned 50,907 shares of the company’s stock, valued at $6,581,766.03. The trade was a 3.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Hawkins Price Performance
NASDAQ HWKN traded up $4.41 on Friday, hitting $134.38. 148,765 shares of the company’s stock were exchanged, compared to its average volume of 171,939. The stock has a 50-day moving average of $144.45 and a 200-day moving average of $155.35. The stock has a market cap of $2.81 billion, a price-to-earnings ratio of 34.02, a P/E/G ratio of 2.73 and a beta of 0.86. Hawkins, Inc. has a 52 week low of $98.30 and a 52 week high of $186.15. The company has a current ratio of 2.35, a quick ratio of 1.46 and a debt-to-equity ratio of 0.49.
Hawkins (NASDAQ:HWKN – Get Free Report) last issued its quarterly earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.75 by ($0.03). Hawkins had a net margin of 7.75% and a return on equity of 16.85%. The business had revenue of $244.08 million during the quarter, compared to the consensus estimate of $252.51 million. Analysts expect that Hawkins, Inc. will post 4 earnings per share for the current year.
Hawkins Announces Dividend
Hedge Funds Weigh In On Hawkins
Large investors have recently modified their holdings of the business. Capital World Investors grew its stake in shares of Hawkins by 618.8% in the third quarter. Capital World Investors now owns 355,619 shares of the specialty chemicals company’s stock worth $64,979,000 after purchasing an additional 306,143 shares during the last quarter. Invesco Ltd. lifted its holdings in Hawkins by 44.4% during the 3rd quarter. Invesco Ltd. now owns 407,793 shares of the specialty chemicals company’s stock worth $74,512,000 after buying an additional 125,444 shares during the period. Schroder Investment Management Group grew its position in shares of Hawkins by 130.7% in the 2nd quarter. Schroder Investment Management Group now owns 149,397 shares of the specialty chemicals company’s stock valued at $21,229,000 after buying an additional 84,651 shares during the last quarter. Granite Investment Partners LLC acquired a new stake in shares of Hawkins in the third quarter valued at about $11,610,000. Finally, Segall Bryant & Hamill LLC increased its stake in shares of Hawkins by 76.1% in the second quarter. Segall Bryant & Hamill LLC now owns 112,431 shares of the specialty chemicals company’s stock valued at $15,976,000 after buying an additional 48,602 shares during the period. Institutional investors own 69.71% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on HWKN shares. BWS Financial reaffirmed a “buy” rating and set a $200.00 price target on shares of Hawkins in a report on Thursday, January 29th. Zacks Research raised shares of Hawkins from a “strong sell” rating to a “hold” rating in a research note on Friday, January 2nd. Finally, Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $162.50.
Check Out Our Latest Report on Hawkins
Hawkins Company Profile
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
See Also
- Five stocks we like better than Hawkins
- What a Former CIA Agent Knows About the Coming Collapse
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Trade this between 9:30 and 10:45 am EST
- Buy this stock tomorrow?
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
